Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Follicular

Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.

1,362 public trials 202 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Follicular trial results

Recruiting

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

NCT06533579

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +40 more
Locations
  • City of Hope Duarte, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • New York Medical College Valhalla, New York, United States
View Trial Details
Recruiting

NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)

NCT07502118

Conditions
Burkitt Lymphoma, Cytokine Release Syndrome, DNA Virus Infections, +29 more
Locations
  • Ankara Bilkent City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
  • Ankara Etlik City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
  • Hacettepe University Faculty of Medicine - Department of Internal Medicine, Division of Hematology Ankara, Turkey (Türkiye)
  • University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Ankara, Turkey (Türkiye)
View Trial Details
Recruiting

Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma

NCT04998669

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Florida Cancer Specialists and Research Institute Fort Myers, Florida, United States
  • University of Miami Miami, Florida, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details
Recruiting

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

NCT04830137

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +36 more
Locations
  • City of Hope Duarte, California, United States
  • University of California Irvine Orange, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
  • Sarah Cannon Research Institute at Colorado Blood Cancer Institute Denver, Colorado, United States
View all 16 locations
View Trial Details

Related conditions